Pradžia › Parkinsono liga › Kanzasas
Parkinsono liga klinikiniai tyrimai Kanzasas
10 tyrimai dėl Parkinsono liga ieško dalyvių vietose Kanzasas.
Miestai Kanzasas
Oficialus tyrimo tekstas (anglų kalba)
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- University of Kansas Medical Center, Kansas City
Renkami dalyviai2 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-10-02 · NCT06680830A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Site-029, Kansas City
Renkami dalyviai2/3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-09-28 · NCT06976268A Study of Buntanetap in Participants With PD
- University of Kansas Medical Center (KUMC) - School of Medicine - Parkinson's Disease and Movement D, Kansas City
Renkami dalyviai2/3 fazė
Amžius nuo 40 iki 85 · Visoms lytims · Atnaujinta 2026-09-21 · NCT07284784A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #041, Overland Park
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-11 · NCT07804615A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- The University of Kansas (KU) (Site #216), Kansas City
Renkami dalyviai2 fazė
Amžius nuo 30 iki 80 · Visoms lytims · Atnaujinta 2026-09-10 · NCT07432958Parkinson's Foundation PD GENEration Genetic Registry
- University of Kansas, Lawrence
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-08 · NCT04994015A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- University of Kansas Medical Center, Kansas City
Renkami dalyviai3 fazė
Amžius nuo 50 iki 85 · Visoms lytims · Atnaujinta 2026-09-03 · NCT07174310A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- University of Kansas Medical Center, Kansas City
Renkami dalyviai3 fazė
Amžius nuo 45 iki 75 · Visoms lytims · Atnaujinta 2026-08-04 · NCT06944522PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- University of Kansas Medical Center, Kansas City
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 30 ir vyresni · Visoms lytims · Atnaujinta 2026-07-27 · NCT04477785A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
- University of Kansas Medical Center, Kansas City
Renkami dalyviai4 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-08-24 · NCT06765668Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.